Patents Assigned to Edwardss Lifesciences Corporation
  • Patent number: 8906601
    Abstract: Methods are provided herein for modifying antigenic carbohydrate epitopes within a xenographic bioprosthetic tissue by oxidation of vicinal diols to form aldehydes or acids and subsequence reductive amination of aldehydes to form stable secondary amines, or amidation or esterification of acids to form stable amides or esters. Advantageously, methods provided herein mitigate the antigenicity of the bioprosthetic tissue while leaving the overall tissue structure substantially undisturbed, and thereby enhance the durability, safety and performance of the bioprosthetic implant.
    Type: Grant
    Filed: June 17, 2011
    Date of Patent: December 9, 2014
    Assignee: Edwardss Lifesciences Corporation
    Inventors: Jeffrey S. Dove, Tara J. Tod